Aldo Frau
Monserrato, 09042, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production.
Journal: Antiviral research
Published: August 19, 2021
Relevance of Ebola virus VP35 homo-dimerization on the type I interferon cascade inhibition.
Journal: Antiviral chemistry & chemotherapy
Published: November 21, 2019
Identification of Myricetin as an Ebola Virus VP35-Double-Stranded RNA Interaction Inhibitor through a Novel Fluorescence-Based Assay.
Journal: Biochemistry
Published: October 10, 2018
Insights into Ebola Virus VP35 and VP24 Interferon Inhibitory Functions and their Initial Exploitation as Drug Targets.
Journal: Infectious disorders drug targets
Published: September 07, 2018
Development and Validation of a Novel Dual Luciferase Reporter Gene Assay to Quantify Ebola Virus VP24 Inhibition of IFN Signaling.
Journal: Viruses
Published: January 11, 2018
Antiviral Agents Against Ebola Virus Infection: Repositioning Old Drugs and Finding Novel Small Molecules.
Journal: Annual reports in medicinal chemistry
Published: January 01, 2018
Broad-range potential of Asphodelus microcarpus leaves extract for drug development.
Journal: BMC microbiology
Published: June 01, 2017
Uvaria angolensis as a promising source of inhibitors of HIV-1 RT-associated RNA-dependent DNA polymerase and RNase H functions.
Journal: Natural product research
Published: May 26, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026